Among the numerous lncRNAs implicated in drug resistance, MALAT1, UCA1, CYTOR, and HOTAIR have emerged as crucial oncogenes, and GAS5 is a well‐known lncRNA that acts as a tumor suppressor in breast cancer [4, 20, 32, 33, 47, 48, 56]. Here, GAS5 is linked to breast cancer.